ORLANDO — Cardiotoxicity from breast cancer drugs was about half as likely with prophylactic use of heart drugs in higher-risk patients, one trial showed, while a second suggested an early trend for less cardiac damage.
March 12, 2018 | by Crystal Phend,Senior Associate Editor, MedPage Today
